INDAZOLE DERIVATIVES
This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the comp...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HOCKERMAN, SUSAN, LANDIS JONES, DARIN, EUGENE KORTUM, STEVEN, WADE TENBRINK, RUTH, ELIZABETH HEDGE, SHRIDHAR, GAJANAN RICO, JOSEPH, GERACE BUCHLER, INGRID, PRICE HAYES, MICHAEL, JOSEPH WU, KUN, KEN |
| description | This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) wherein R1, R2 and R3 are as defined in this specification.
Cette invention concerne des composés, des compositions pharmaceutiques et des méthodes de traitement d'une pathologie induite par l'activité du récepteur CB1 chez un mammifère, notamment chez l'homme. Ces méthodes consistent à administrer à un mammifère nécessitant un tel traitement une quantité thérapeutiquement efficace du composé de formule (I), dans laquelle R1, R2 et R3 sont tels que définis dans la description. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2009106982A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2009106982A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2009106982A13</originalsourceid><addsrcrecordid>eNrjZBDx9HNxjPL3cVVwcQ3yDHMM8QxzDeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGBpaGBmaWFkaOhsbEqQIAAMMfsQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INDAZOLE DERIVATIVES</title><source>esp@cenet</source><creator>HOCKERMAN, SUSAN, LANDIS ; JONES, DARIN, EUGENE ; KORTUM, STEVEN, WADE ; TENBRINK, RUTH, ELIZABETH ; HEDGE, SHRIDHAR, GAJANAN ; RICO, JOSEPH, GERACE ; BUCHLER, INGRID, PRICE ; HAYES, MICHAEL, JOSEPH ; WU, KUN, KEN</creator><creatorcontrib>HOCKERMAN, SUSAN, LANDIS ; JONES, DARIN, EUGENE ; KORTUM, STEVEN, WADE ; TENBRINK, RUTH, ELIZABETH ; HEDGE, SHRIDHAR, GAJANAN ; RICO, JOSEPH, GERACE ; BUCHLER, INGRID, PRICE ; HAYES, MICHAEL, JOSEPH ; WU, KUN, KEN</creatorcontrib><description>This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) wherein R1, R2 and R3 are as defined in this specification.
Cette invention concerne des composés, des compositions pharmaceutiques et des méthodes de traitement d'une pathologie induite par l'activité du récepteur CB1 chez un mammifère, notamment chez l'homme. Ces méthodes consistent à administrer à un mammifère nécessitant un tel traitement une quantité thérapeutiquement efficace du composé de formule (I), dans laquelle R1, R2 et R3 sont tels que définis dans la description.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090903&DB=EPODOC&CC=WO&NR=2009106982A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090903&DB=EPODOC&CC=WO&NR=2009106982A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HOCKERMAN, SUSAN, LANDIS</creatorcontrib><creatorcontrib>JONES, DARIN, EUGENE</creatorcontrib><creatorcontrib>KORTUM, STEVEN, WADE</creatorcontrib><creatorcontrib>TENBRINK, RUTH, ELIZABETH</creatorcontrib><creatorcontrib>HEDGE, SHRIDHAR, GAJANAN</creatorcontrib><creatorcontrib>RICO, JOSEPH, GERACE</creatorcontrib><creatorcontrib>BUCHLER, INGRID, PRICE</creatorcontrib><creatorcontrib>HAYES, MICHAEL, JOSEPH</creatorcontrib><creatorcontrib>WU, KUN, KEN</creatorcontrib><title>INDAZOLE DERIVATIVES</title><description>This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) wherein R1, R2 and R3 are as defined in this specification.
Cette invention concerne des composés, des compositions pharmaceutiques et des méthodes de traitement d'une pathologie induite par l'activité du récepteur CB1 chez un mammifère, notamment chez l'homme. Ces méthodes consistent à administrer à un mammifère nécessitant un tel traitement une quantité thérapeutiquement efficace du composé de formule (I), dans laquelle R1, R2 et R3 sont tels que définis dans la description.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDx9HNxjPL3cVVwcQ3yDHMM8QxzDeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGBpaGBmaWFkaOhsbEqQIAAMMfsQ</recordid><startdate>20090903</startdate><enddate>20090903</enddate><creator>HOCKERMAN, SUSAN, LANDIS</creator><creator>JONES, DARIN, EUGENE</creator><creator>KORTUM, STEVEN, WADE</creator><creator>TENBRINK, RUTH, ELIZABETH</creator><creator>HEDGE, SHRIDHAR, GAJANAN</creator><creator>RICO, JOSEPH, GERACE</creator><creator>BUCHLER, INGRID, PRICE</creator><creator>HAYES, MICHAEL, JOSEPH</creator><creator>WU, KUN, KEN</creator><scope>EVB</scope></search><sort><creationdate>20090903</creationdate><title>INDAZOLE DERIVATIVES</title><author>HOCKERMAN, SUSAN, LANDIS ; JONES, DARIN, EUGENE ; KORTUM, STEVEN, WADE ; TENBRINK, RUTH, ELIZABETH ; HEDGE, SHRIDHAR, GAJANAN ; RICO, JOSEPH, GERACE ; BUCHLER, INGRID, PRICE ; HAYES, MICHAEL, JOSEPH ; WU, KUN, KEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2009106982A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HOCKERMAN, SUSAN, LANDIS</creatorcontrib><creatorcontrib>JONES, DARIN, EUGENE</creatorcontrib><creatorcontrib>KORTUM, STEVEN, WADE</creatorcontrib><creatorcontrib>TENBRINK, RUTH, ELIZABETH</creatorcontrib><creatorcontrib>HEDGE, SHRIDHAR, GAJANAN</creatorcontrib><creatorcontrib>RICO, JOSEPH, GERACE</creatorcontrib><creatorcontrib>BUCHLER, INGRID, PRICE</creatorcontrib><creatorcontrib>HAYES, MICHAEL, JOSEPH</creatorcontrib><creatorcontrib>WU, KUN, KEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HOCKERMAN, SUSAN, LANDIS</au><au>JONES, DARIN, EUGENE</au><au>KORTUM, STEVEN, WADE</au><au>TENBRINK, RUTH, ELIZABETH</au><au>HEDGE, SHRIDHAR, GAJANAN</au><au>RICO, JOSEPH, GERACE</au><au>BUCHLER, INGRID, PRICE</au><au>HAYES, MICHAEL, JOSEPH</au><au>WU, KUN, KEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INDAZOLE DERIVATIVES</title><date>2009-09-03</date><risdate>2009</risdate><abstract>This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective amount of the compound of formula (I) wherein R1, R2 and R3 are as defined in this specification.
Cette invention concerne des composés, des compositions pharmaceutiques et des méthodes de traitement d'une pathologie induite par l'activité du récepteur CB1 chez un mammifère, notamment chez l'homme. Ces méthodes consistent à administrer à un mammifère nécessitant un tel traitement une quantité thérapeutiquement efficace du composé de formule (I), dans laquelle R1, R2 et R3 sont tels que définis dans la description.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2009106982A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INDAZOLE DERIVATIVES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T08%3A18%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HOCKERMAN,%20SUSAN,%20LANDIS&rft.date=2009-09-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2009106982A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |